
The Network for Drug Discovery & Development Berlin-Brandenburg started in 2007 as an open interdisciplinary initiative with the aim to accelerate the transfer of clinical relevant findings into innovative drugs and therapeutic concepts.
Supporting a joint effort of several Max Planck Institutes the Max Planck Society establishes a Chemical Genomics Centre. Within this collaborative effort researchers focus on the chemical-biological analysis of biological phenomena through the use of small molecules.